Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
Journal of Diabetes Research · 2023
DOI: 10.1155/2023/8542262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2023. Verfasst von Wei Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Guangzhou, University of Chinese Medicine, Guangzhou, 510210 Guangdong Province, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Hospital of Traditional Chinese Medicine, Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Science and Technology Department.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. Our study investigated the short-term effect of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in perioperative T2DM patients using the data envelopment analysis (DEA).
Methods
T2DM patients ( n = 639 ) who underwent surgeries in Guangdong Provincial Hospital of Traditional Chinese Medicine (2009.01-2017.12) were included. Insulin was provided to each patient during the study and separated into a CSII group ( n = 369 ) and an MDI group ( n = 270 ). DEA was performed to compare the therapeutic indexes and investigate the short-term effect of the CSII group and MDI group.
Results
Scale efficiencies of the CSII group with CCR model and BCC model were better than that of the MDI group. Regarding slack variables, with higher surgical levels, the CSII group was closer to the ideal state than the MDI group, which indicated in improving the average fasting blood glucose (AFBG), antibiotic use days (AUD), preoperative blood glucose control time (PBGCT), first postoperative day fasting blood glucose (FPDFBG), and postoperative hospitalization days (PHD).
Conclusion
CSII could effectively control blood glucose levels and shorten perioperative hospitalizing time for T2DM patients, indicating that CSII was beneficial in perioperative period and should be promoted clinically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Guangzhou, University of Chinese Medicine, Guangzhou, 510210 Guangdong Province, China.
- Department of Endocrinology, Huizhou Hospital of Guangzhou, University of Chinese Medicine, Huizhou, 516000 Guangdong Province, China.
- Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, 510120 Guangdong Province, China.
ORCID-Profile: Yu Zhang, Guanjie Fan, Ling Zhao
Förderung
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Science and Technology Department
- National Research Program of China
Zitieren
APA
Song, W., Wen, J., Zhang, J., Luo, M., Hu, Y., Zhang, Y., Fan, G., & Zhao, L. (2023). Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. https://doi.org/10.1155/2023/8542262
Vancouver
Song W, Wen J, Zhang J, Luo M, Hu Y, Zhang Y, et al. Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2023. doi:10.1155/2023/8542262
BibTeX
@article{Song2023,
author = {Song, Wei and Wen, Jianxuan and Zhang, Jinming and Luo, Meng and Hu, Yue and Zhang, Yu and Fan, Guanjie and Zhao, Ling},
title = {Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus},
journal = {Journal of Diabetes Research},
year = {2023},
doi = {10.1155/2023/8542262}
}
EUVIMED